Login

Journal Front Page

News & Events

  • Call for article for January 2025 issue
    • Submissions of Review, Research Article, Short Communication and Case study are being accepted for the current and future issues before 15 December, 2024 of this journal by online process or editor@ajper.com, or ajper.editor@gmail.com. Further information can be found at www.ajper.com.
  • October 2024 Issue published
    • Dear Researcher, It Pleased to inform you that, Asian Journal of Pharmaceutical Education and Research, has successfully launch Volume 13, Issue 4 (October 2024 Issue). You can find the article on http://ajper.com/current_issue.php Article also invited for the Next coming Issue from your side. For More details Visit: www.ajper.com
  • Application For Reviewer
    • We are now going to reconstitute our editorial board members of Reviewer. Please send your resume at ajper.editor@gmail.com and be a part of the editorial board member as Reviewer.
  • AJPER Impact facor
    • It is to pleasure that Ajper SJIF imact facor has increse from 5.019 to 7.014. Also global impact factor incresed from 0.654 to 0.765.
  • ICV
    • AJPER Rank with Index Copernicus Value 61.10 due to high reputation at International Level

Abstract

A SYSTEMIC REVIEW ON BREAST CANCER AND ITS TREATMENT

Pramod Kumar, Rashmi Pandey*, Naimish Nanda, Sandip Prasad Tiwari

Faculty of Pharmacy, Kalinga University, Naya Raipur, Chhattisgarh India (492101)

ABSTRACT

Breast cancer stands as a formidable global health challenge, marked by its intricate origins and formidable hurdles in both prevention and treatment. This comprehensive review delves into the pivotal role of drug carriers, particularly nanocarriers, in confronting these obstacles, with a specific emphasis on metastatic breast cancer. Through an exhaustive exploration, a variety of nanocarriers such as liposomes, solid lipid nanoparticles, dendrimers, micelles, gold nanoparticles, and nanofibers are meticulously analyzed for their potential to modulate drug distribution and pharmacokinetics. By doing so, they enable precise control over drug release mechanisms and facilitate targeted therapy approaches. Highlighting the remarkable strides in nanotechnology, this review underscores its transformative impact in breast cancer treatment. Leveraging the distinctive properties of nanocarriers not only promises to surmount existing limitations but also holds the potential to revolutionize patient outcomes. As a result, this nuanced approach heralds a new era of heightened treatment efficacy and precision in the battle against breast cancer, offering renewed hope for millions worldwide.

Keywords: Breast Cancer, Ductal carcinoma, Estrogen, Lymph


[Full Text Article]